Moderna | MRNA - PE Price to Earnings

Stock Price
48.89
Daily Change
-1.84 -3.63%
Monthly
1.37%
Yearly
78.04%
Q2 Forecast
49.64

Moderna reported 27.22 in PE Price to Earnings for its fiscal quarter ending in June of 2023.





Pe Change Date
Acadia Pharmaceuticals 11.61 2.09 Dec/2025
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amgen 25.31 15.82 Dec/2025
Biogen 14.02 4.63 Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Celltrion 50.09 23.24 Sep/2025
Cspc Pharmaceutical 24.4 1.13 Dec/2025
Deva Holding AS 6.55 2.01 Sep/2023
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 66.5 5.69 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Gilead Sciences 15.63 0.08 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
Incyte 14.84 2.79 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Kangmei Pharma 3.15K 624.19 Jun/2025
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Malin Corporation 11.81 0.72 Jun/2023
Moderna 27.22 14.51 Jun/2023
Organigram Holdings 235 224.49 Sep/2025
Ovoca Bio 1.83 3.29 Jun/2024
Pharma Mar 17.41 29.74 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Qiagen NV 20.54 0.1 Dec/2025
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Sarepta Therapeutics 27.27 0 Sep/2025
Sartorius 43.44 84.64 Mar/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Tilray 11.56 80.19 Sep/2025
United Therapeutics 17.32 1.62 Dec/2025
Vertex Pharmaceuticals 26.15 2.22 Dec/2025
Zealand Pharma A/S 5.13 0.16 Dec/2025
Zz Pientze Pharmaceu 49.04 4.33 Sep/2025